Cyclin A1 regulates WT1 expression in acute myeloid leukemia cells

International Journal of Oncology

Volumn 34, Issue 1, 2009, Pages 129-136

  Krug, Utz ^a   Yasmeen, Amber ^a   Beger, Carmela ^b   Bäumeri, Nicole ^a   Dugas, Martin ^a   Berdel, Wolfgang E ^a   Müller Tidow, Carsten ^a,c  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Acute myeloid leukemia; Cyclin A1; Isoforms; WT1

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN A1; ISOPROTEIN; MESSENGER RNA; WT1 PROTEIN; CCNA1 PROTEIN, HUMAN; CCNA1 PROTEIN, MOUSE; CYCLIN A; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; BONE MARROW; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL GROWTH; CELL STRAIN U937; COLONY FORMATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE REPRESSION; GENE TARGETING; GENETIC TRANSFECTION; GROWTH INHIBITION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKEMOGENESIS; LIVER PARENCHYMA; MICROARRAY ANALYSIS; OVARY; PRIORITY JOURNAL; ANIMAL; CLONOGENIC ASSAY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; MOUSE; MOUSE MUTANT; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BONE MARROW; CELL LINE, TUMOR; COLONY-FORMING UNITS ASSAY; CYCLIN A; G1 PHASE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; MICE; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION; U937 CELLS; WT1 PROTEINS;

EID: 60749125058     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000136     Document Type: Article

References (39)

1. Yang R, Morosetti R and Koeffler HP: Characterization of a second human cyclin A that is highly expressed in testis and in several leukemic cell lines. Cancer Res 57: 913-920, 1997.
2. Sweeney C, Murphy M, Kubelka M, Ravnik SE, Hawkins CF, Wolgemuth DJ and Carrington M: A distinct cyclin A is expressed in germ cells in the mouse. Development 122: 53-64, 1996.
3. Yang R, Muller C, Huynh V, Fung YK, Yee AS and Koeffler HP: Functions of cyclin A1 in the cell cycle and its interactions with transcription factor E2F-1 and the Rb family of proteins. Mol Cell Biol 19: 2400-2407, 1999.
4. Muller-Tidow C, Wang W, Idos GE, et al: Cyclin A1 directly interacts with B-myb and cyclin A1/cdk2 phosphorylate B-myb at functionally important serine and threonine residues: tissue-specific regulation of B-myb function. Blood 97: 2091-2097, 2001.
5. Liu D, Matzuk MM, Sung WK, Guo Q, Wang P and Wolgemuth DJ: Cyclin A1 is required for meiosis in the male mouse. Nat Genet 20: 377-380, 1998.
6. Yang R, Nakamaki T, Lubbert M, et al: Cyclin A1 expression in leukemia and normal hematopoietic cells. Blood 93: 2067-2074, 1999.
7. Liao C, Wang XY, Wei HQ, Li SQ, Merghoub T, Pandolfi PP and Wolgemuth DJ: Altered myelopoiesis and the development of acute myeloid leukemia in transgenic mice overexpressing cyclin A1. Proc Natl Acad Sci USA 98: 6853-6858, 2001.
8. Tusher VG, Tibshirani R and Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121, 2001.
9. Muller-Tidow C, Bornemann C, Diederichs S, et al: Analyses of the genomic methylation status of the human cyclin A1 promoter by a novel real-time PCR-based methodology. FEBS Lett 490: 75-78, 2001.
10. Inoue K, Tamaki H, Ogawa H, et al: Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells. Blood 91: 2969-2976, 1998.
11. Smith SI, Weil D, Johnson GR, Boyd AW and Li CL: Expression of the Wilms' tumor suppressor gene, WT1, is upregulated by leukemia inhibitory factor and induces monocytic differentiation in M1 leukemic cells. Blood 91: 764-773, 1998.
12. Smith SI, Down M, Boyd AW and Li CL: Expression of the Wilms' tumor suppressor gene, WT1, reduces the tumorigenicity of the leukemic cell line M1 in C.B-17 scid/scid mice. Cancer Res 60: 808-814, 2000.
13. Haber DA, Sohn RL, Buckler AJ, Pelletier J, Call KM and Housman DE: Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc Natl Acad Sci USA 88: 9618-9622, 1991.
14. Klamt B, Koziell A, Poulat F, Wieacker P, Scambler P, Berta P and Gessler M: Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1 +/-KTS splice isoforms. Hum Mol Genet 7: 709-714, 1998.
15. Baudry D, Faussillon M, Cabanis MO, et al: Changes in WT1 splicing are associated with a specific gene expression profile in Wilms' tumour. Oncogene 21: 5566-5573, 2002.
16. Scharnhorst V, van der Eb AJ and Jochemsen AG: WT1 proteins: functions in growth and differentiation. Gene 273: 141-161, 2001.
17. Fraizer GC, Patmasiriwat P, Zhang X and Saunders GF: Expression of the tumor suppressor gene WT1 in both human and mouse bone marrow. Blood 86: 4704-4706, 1995.
18. Miwa H, Beran M and Saunders GF: Expression of the Wilms' tumor gene (WT1) in human leukemias. Leukemia 6: 405-409, 1992.
19. Sekiya M, Adachi M, Hinoda Y, Imai K and Yachi A: Down-regulation of Wilms' tumor gene (wt1) during myelomonocytic differentiation in HL60 cells. Blood 83: 1876-1882, 1994.
20. Svedberg H, Chylicki K, Baldetorp B, Rauscher FJ III and Gullberg U: Constitutive expression of the Wilms' tumor gene (WT1) in the leukemic cell line U937 blocks parts of the differentiation program. Oncogene 16: 925-932, 1998.
21. Glienke W, Maute L, Koehl U, Esser R, Milz E and Bergmann L: Effective treatment of leukemic cell lines with wt1 siRNA. Leukemia 21: 2164-2170, 2007.
22. Rosenfeld C, Cheever MA and Gaiger A: WT1 in acute leukemia, chronic myelogenous leukemia and myelodysplastic syndrome: therapeutic potential of WT1 targeted therapies. Leukemia 17: 1301-1312, 2003.
23. King-Underwood L and Pritchard-Jones K: Wilms' tumor (WT1) gene mutations occur mainly in acute myeloid leukemia and may confer drug resistance. Blood 91: 2961-2968, 1998.
24. Kim TY and Kaelin WG Jr: Differential control of transcription by DNA-bound cyclins. Mol Biol Cell 12: 2207-2217, 2001.
25. Gessler M, Konig A and Bruns GA: The genomic organization and expression of the WT1 gene. Genomics 12: 807-813, 1992.
26. Rupprecht HD, Drummond IA, Madden SL, Rauscher FJ III and Sukhatme VP: The Wilms' tumor suppressor gene WT1 is negatively autoregulated. J Biol Chem 269: 6198-6206, 1994.
27. Rauscher FJ III, Morris JF, Tournay OE, Cook DM and Curran T: Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. Science 250: 1259-1262, 1990.
28. Bickmore WA, Oghene K, Little MH, van Heyningen V, Seawright A and Hastie ND: Modulation of DNA binding specificity by alternative splicing of the Wilms tumor wt1 gene transcript. Science 257: 235-237, 1992.
29. Morris JF, Madden SL, Tournay OE, Cook DM, Sukhatme VP and Rauscher FJ III: Characterization of the zinc finger protein encoded by the WT1 Wilms' tumor locus. Oncogene 6: 2339-2348, 1991.
30. Kohsaka T, Tagawa M, Takekoshi Y, Yanagisawa H, Tadokoro K and Yamada M: Exon 9 mutations in the WT1 gene, without influencing KTS splice isoforms, are also responsible for Frasier syndrome. Hum Mutat 14: 466-470, 1999.
31. Natoli TA, Liu J, Eremina V, et al: A mutant form of the Wilms' tumor suppressor gene WT1 observed in Denys-Drash syndrome interferes with glomerular capillary development. J Am Soc Nephrol 13: 2058-2067, 2002.
32. Natoli TA, McDonald A, Alberta JA, Taglienti ME, Housman DE and Kreidberg JA: A mammal-specific exon of WT1 is not required for development or fertility. Mol Cell Biol 22: 4433-4438, 2002.
33. Svedberg H, Richter J and Gullberg U: Forced expression of the Wilms tumor 1 (WT1) gene inhibits proliferation of human hematopoietic CD34(+) progenitor cells. Leukemia 15: 1914-1922, 2001.
34. Ellisen LW, Carlesso N, Cheng T, Scadden DT and Haber DA: The Wilms tumor suppressor WT1 directs stage-specific quiescence and differentiation of human hematopoietic progenitor cells. EMBO J 20: 1897-1909, 2001.
35. Murata Y, Kudoh T, Sugiyama H, Toyoshima K and Akiyama T: The Wilms tumor suppressor gene WT1 induces G1 arrest and apoptosis in myeloblastic leukemia M1 cells. FEBS Lett 409: 41-45, 1997.
36. Englert C, Hou X, Maheswaran S, et al: WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J 14: 4662-4675, 1995.
37. Menke AL, Shvarts A, Riteco N, van Ham RC, van der Eb AJ and Jochemsen AG: Wilms' tumor 1-KTS isoforms induce p53-independent apoptosis that can be partially rescued by expression of the epidermal growth factor receptor or the insulin receptor. Cancer Res 57: 1353-1363, 1997.
38. Kudoh T, Ishidate T, Moriyama M, Toyoshima K and Akiyama T: G1 phase arrest induced by Wilms tumor protein WT1 is abrogated by cyclin/CDK complexes. Proc Natl Acad Sci USA 92: 4517-4521, 1995.
39. Kudoh T, Ishidate T, Nakamura T, Toyoshima K and Akiyama T: Constitutive expression of the Wilms tumor suppressor gene WT1 in F9 embryonal carcinoma cells induces apoptotic cell death in response to retinoic acid. Oncogene 13: 1431-1439, 1996.